{
    "address": "Medicon Village, Scheelevagen 2",
    "city": "Lund",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W2R056269",
    "description": "Combigene AB is a SE-based company operating in Biotechnology industry. The company is headquartered in Lund, Skane. The company went IPO on 2015-05-25. Combigene AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The firm specializes in development of treatments for neurological disorders. The firm's platform comprises the use of gene therapy vectors delivering a combination of transgenes encoding two or more of neuropeptide Y (NPY) receptors, galanin, galanin receptors, somatostatin, and somatostatin receptors, for the treatment of neurological and psychiatric diseases in humans and animals. The firm focuses on the development of an epilepsy treatment by means of an adeno-associated virus (AAV) vector carrying the transgenes for the neurotransmitter NPY and one of its receptors, the G protein-coupled receptor Y2.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Biotechnology",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "ipo": "2015-05-25",
    "isin": "SE0016101935",
    "logo": "https://finnhub.io/api/logo?symbol=COMBI.ST",
    "marketCapitalization": 132.272,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in Biotechnology",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "Combigene AB",
    "phone": "",
    "sedol": "BN44PZ8",
    "shareOutstanding": 19.801197,
    "state": "SKANE",
    "ticker": "COMBI.ST",
    "weburl": "http://combigene.com/"
}